SCHEMBL20346753

SCHEMBL20346753

Cc1cccc2c(=O)c3ccc4cc5c(cc4c3oc12)OCO5

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.45
▸ PRNP P04156 1/20 0.45
▸ BCL2L1 Q07817 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ BAK1 Q16611 1/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ GLA P06280 1/20 0.39
▸ STING1 Q86WV6 1/20 0.39
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALOX5 P09917 1/20 0.37
▸ PRKDC P78527 2/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ HPGD P15428 4/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ MAPT P10636 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20346717 0.85 PRNP (0.44) POLBPRNPBCL2L1MCL1BAK1
SCHEMBL20346752 0.85 BCL2L1 (0.39) POLBPRNPBCL2L1MCL1BAK1
SCHEMBL20346762 0.84 NPC1 (0.41) BCL2L1MCL1BAK1KMT2ANPC1
SCHEMBL20350031 0.84 MAOA (0.52) POLBKMT2ANPC1RAB9AL3MBTL1
SCHEMBL20346764 0.81 ALDH1A1 (0.38) BCL2L1MCL1BAK1KMT2ANPC1
SCHEMBL20346763 0.79 ALDH1A1 (0.42) POLBBCL2L1MCL1BAK1KMT2A
SCHEMBL20346751 0.78 KDM4E (0.40) BCL2L1MCL1BAK1KMT2ANPC1
SCHEMBL9379369 0.76 MCL1 (0.52) MCL1GLASTING1NPC1RAB9A
SCHEMBL20346767 0.74 PDE5A (0.41) BCL2L1MCL1BAK1KMT2ANPC1
SCHEMBL20350033 0.74 MAOA (0.54) POLBKMT2ANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180185325-A1 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, NR1H2, NR1H3 POLB 2424/4885PRNP 2062/4885BCL2L1 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback